Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 04.07.17 in Vol 19, No 7 (2017): July

This paper is in the following e-collection/theme issue:

Works citing "Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis"

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.7306):

(note that this is only a small subset of citations)

  1. Kelly BJ, Rupert DJ, Aikin KJ, Sullivan HW, Johnson M, Bann CM, Mack N, Southwell BG, West S, Parvanta S, Rabre A, Peinado S. Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising. Research in Social and Administrative Pharmacy 2021;17(5):942
    CrossRef
  2. Alkazemi MF, Van Stee SK. Electronic direct-to-consumer advertising of pharmaceuticals: an assessment of textual and visual content of websites. Health Education Research 2020;35(2):134
    CrossRef
  3. Giombi K, Thompson J, Wines C, Haughney R, Sullivan HW, Betts KR. A scoping review of empirical research on prescription drug promotion. Research in Social and Administrative Pharmacy 2023;19(6):859
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/jmir.7306):

  1. . Institutionelle Korruption und Arzneimittelvertrieb. 2019. Chapter 13:295
    CrossRef
  2. . Institutionelle Korruption und Arzneimittelvertrieb. 2019. Chapter 12:261
    CrossRef